These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11240657)

  • 1. Workshop Report: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society.
    Kohorn EI; Goldstein DP; Hancock BW; Kim SJ; Lurain JR; Newlands E; Soper JT; Wong LC
    Int J Gynecol Cancer; 2000 Jan; 10(1):84-88. PubMed ID: 11240657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report.
    Kohorn EI
    J Reprod Med; 2002 Jun; 47(6):445-50. PubMed ID: 12092012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
    Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
    Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment.
    Kohorn EI
    Int J Gynecol Cancer; 2001; 11(1):73-7. PubMed ID: 11285037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy.
    Goldstein DP; Zanten-Przybysz IV; Bernstein MR; Berkowitz RS
    J Reprod Med; 1998 Jan; 43(1):37-43. PubMed ID: 9475148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gestational trophoblastic neoplasia according to the FIGO 2000 staging and scoring system: a 20 years' experience.
    Wang KL; Yang YC; Wang TY; Cheng-Yen Lai J; Chen TC; Chang CL
    Acta Obstet Gynecol Scand; 2009; 88(2):204-8. PubMed ID: 19031297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging and assessing trophoblastic tumors. A possible solution to an intractable problem.
    Kohorn EI
    J Reprod Med; 1998 Jan; 43(1):33-6. PubMed ID: 9475147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics.
    Pecorelli S; Benedet JL; Creasman WT; Shepherd JH
    Int J Gynaecol Obstet; 1999 Jan; 64(1):5-10. PubMed ID: 10190664
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of risk categorization in gestational trophoblastic tumor between old and new combined staging and scoring system.
    Tocharoenvanich S; Chichareon S; Wootipoom V; Bu-ngachat R; Piyananjarassri K
    J Obstet Gynaecol Res; 2003 Feb; 29(1):20-7. PubMed ID: 12696623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic staging and risk factor scoring for gestational trophoblastic disease.
    Kohorn EI
    Int J Gynecol Cancer; 2007; 17(5):1124-30. PubMed ID: 17386047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics.
    Pecorelli S; Benedet JL; Creasman WT; Shepherd JH
    Int J Gynaecol Obstet; 1999 Jun; 65(3):243-9. PubMed ID: 10428343
    [No Abstract]   [Full Text] [Related]  

  • 12. Dutch Risk Classification and FIGO 2000 for Gestational Trophoblastic Neoplasia Compared.
    Eysbouts YK; Massuger L; Thomas C; Ottevanger P; Short D; Harvey R; Sebire N; Kaur B; Naveed S; Sweep F; Seckl M
    Int J Gynecol Cancer; 2016 Nov; 26(9):1712-1716. PubMed ID: 27654257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients.
    Jiang F; Wan XR; Xu T; Feng FZ; Ren T; Yang JJ; Zhao J; Yang T; Xiang Y
    Gynecol Oncol; 2018 Jun; 149(3):539-544. PubMed ID: 29653688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia.
    Clark LH; Staley SA; Barber EL; Wysham WZ; Kim KH; Soper JT
    Am J Obstet Gynecol; 2016 Aug; 215(2):217.e1-5. PubMed ID: 26875944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of the FIGO cancer staging system.
    Odicino F; Pecorelli S; Zigliani L; Creasman WT
    Int J Gynaecol Obstet; 2008 May; 101(2):205-10. PubMed ID: 18199437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015).
    Tempfer C; Horn LC; Ackermann S; Beckmann MW; Dittrich R; Einenkel J; Günthert A; Haase H; Kratzsch J; Kreissl MC; Polterauer S; Ebert AD; Schneider KT; Strauss HG; Thiel F
    Geburtshilfe Frauenheilkd; 2016 Feb; 76(2):134-144. PubMed ID: 26941444
    [No Abstract]   [Full Text] [Related]  

  • 17. [Staging of malignant trophoblast diseases: a dilemma].
    Köchli OR
    Gynakol Geburtshilfliche Rundsch; 1994; 34(1):3-6. PubMed ID: 8019169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hCG level and rising world health organization score at second-line chemotherapy (pulse dactinomycin): poor prognostic factors for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM
    Int J Gynecol Cancer; 2010 Nov; 20(8):1424-8. PubMed ID: 21051988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The International Society of Gynecological Pathologists. Its founding and early years.
    Salazar H; Scully RE
    Int J Gynecol Pathol; 2000 Jan; 19(1):3-6. PubMed ID: 10638448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
    Chalouhi GE; Golfier F; Soignon P; Massardier J; Guastalla JP; Trillet-Lenoir V; Schott AM; Raudrant D
    Am J Obstet Gynecol; 2009 Jun; 200(6):643.e1-6. PubMed ID: 19393597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.